Phlow Corp. is a U.S.-based contract development and manufacturing organization that offers integrated small‑molecule API development, analytical support, and scalable cGMP production on a single campus. Its facilities provide flexible kilo‑scale batches for preclinical and clinical work as well as metric‑ton‑scale lines for commercial manufacturing, reducing lead times and enhancing supply‑chain security for pharmaceutical companies and government agencies.
Funding
$37M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical companies and government agencies face increasing risk from global supply chain disruptions, limited domestic capacity for small‑molecule active pharmaceutical ingredient (API) production, and rising costs associated with overseas manufacturing.
Solution
Phlow provides a U.S.-based contract development and manufacturing organization (CDMO) that integrates early‑stage process research, analytical support, and scalable cGMP production within a single, purpose‑built campus. The company offers flexible kilo‑scale facilities for preclinical and clinical material and metric‑ton‑scale lines for commercial‑volume manufacturing, all operating under U.S. regulatory standards. By consolidating development and manufacturing in the Eastern time zone, Phlow reduces lead times, enhances supply chain security, and enables pharmaceutical firms to meet domestic sourcing requirements. The integrated approach also supports rapid scale‑up from laboratory to full‑scale production while maintaining consistent quality and compliance.
Target Audience
Primary customers are pharmaceutical companies and U.S. government agencies seeking domestic, reliable, and scalable small‑molecule API development and manufacturing capabilities.
Features
- Dedicated process research and development labs with analytical capabilities for seamless scale‑up
- Flexible kilo‑scale cGMP facility for small‑batch preclinical and clinical API production
- High‑volume metric‑ton‑scale cGMP facility designed for commercial‑ready manufacturing
- End‑to‑end integration of development and manufacturing on a single U.S. campus
- Compliance with the highest U.S. cGMP standards and regulatory requirements
- Eastern U.S. timezone operations to align with domestic pharmaceutical partners
- Scalable infrastructure that can be rapidly expanded to meet increasing demand